title: Sepsis and the heart.
abstract: Septic shock, the most severe complication of sepsis, accounts for approximately 10% of all admissions to intensive care. Our understanding of its complex pathophysiology remains incomplete but clearly involves stimulation of the immune system with subsequent inflammation and microvascular dysfunction. Cardiovascular dysfunction is pronounced and characterized by elements of hypovolaemic, cytotoxic, and distributive shock. In addition, significant myocardial depression is commonly observed. This septic cardiomyopathy is characterized by biventricular impairment of intrinsic myocardial contractility, with a subsequent reduction in left ventricular (LV) ejection fraction and LV stroke work index. This review details the myocardial dysfunction observed in adult septic shock, and discusses the underlying pathophysiology. The utility of using the regulatory protein troponin for the detection of myocardial dysfunction is also considered. Finally, options for the management of sepsis-induced LV hypokinesia are discussed, including the use of levosimendan.
authors: Macclesfield District General Hospital, Victoria Road, Macclesfield SK10 3BL, UK. jdhunter@talk21.com
authors: J D
authors: JD
authors: Hunter
authors: M
authors: M
authors: Doddi
mesh_terms: D015415:Biomarkers / Q000097:blood; D006801:Humans; D011379:Prognosis; D012772:Shock, Septic / Q000150:complications* / Q000503:physiopathology; D014336:Troponin / Q000097:blood; D018754:Ventricular Dysfunction / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
chemical_list: D015415:Biomarkers; D014336:Troponin